# Current Good Manufacturing Practices for Blood and Blood Components: Notification of Consignees Receiving Blood and Blood Components at Increased Risk for Transmitting HIV Infection; Correction of Effective Date
> **Food and Drug Administration** · Final rule; correction of effective date. · Published 1996-12-19 · Effective 1996-09-09 · 61 FR 66919
## Document
- **Document number:** 96-32271
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 61 FR 66919
- **CFR reference:** 21 CFR 606
- **Publication date:** 1996-12-19
- **Effective date:** 1996-09-09
- **HHS docket:** Docket No. 91N-0152
## Abstract

The Food and Drug Administration (FDA) is correcting a final rule on current good manufacturing practices for blood and blood components, that appeared in the Federal Register of September 9, 1996 (61 FR 47413). The document was published with an incorrect effective date. The effective date had been inadvertently switched with the comment deadline for the information collection requirements. This document corrects those errors.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1996/12/19/96-32271/current-good-manufacturing-practices-for-blood-and-blood-components-notification-of-consignees)
---
*AI Analytics · CC0 1.0*